KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
KDNY
Delisted
KDNY was delisted on the 10th of August, 2023.
82 hedge funds and large institutions have $110M invested in Chinook Therapeutics, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 21 increasing their positions, 29 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
82
Holders Change
-2
Holders Change %
-2.38%
% of All Funds
1.81%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
19
Increased
21
Reduced
29
Closed
19
Calls
$235K
Puts
–
Net Calls
+$235K
Net Calls Change
+$204K
Top Buyers
| 1 |
VC
Vivo Capital
Palo Alto,
California
|
+$14M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
+$4.93M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$4.63M |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$2.39M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$1.15M |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$1.92M |
| 2 |
Two Sigma Investments
New York
|
-$1.25M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.04M |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$847K |
| 5 |
D.E. Shaw & Co
New York
|
-$776K |
